IDH2 and central nervous system cancer: A number of studies have investigated the potential of exclusive MRI or PET imaging to predict IDH mutation (32), suggesting potential differences between the uptake patterns of different amino acid PET tracers in gliomas due to the specific metabolic profiles of IDH-mutated gliomas.